ZD-1611

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZD-1611
Drug Alias NameZD-1611
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonists
TargetsEndothelin receptor type A
Therapy Area/IndicationsHypertensionHeart FailurePulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionHeart FailurePulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A